vasopressin - early initiation — Competitive Intelligence Brief

vasopressin - early initiation (vasopressin - early initiation) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vasopressor agent. Area: Critical Care / Sepsis.

marketed Vasopressor agent Vasopressin receptor (V1 and V2) Critical Care / Sepsis Small molecule

Target snapshot

vasopressin - early initiation (vasopressin - early initiation) — The Cleveland Clinic. Vasopressin is a naturally occurring hormone that binds to vasopressin receptors to increase blood pressure and vasoconstriction, used in early septic shock management to restore hemodynamic stability.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
vasopressin - early initiation TARGET	vasopressin - early initiation	The Cleveland Clinic	marketed	Vasopressor agent	Vasopressin receptor (V1 and V2)
Vasopressin intravenous infusion	Vasopressin intravenous infusion	University of Sao Paulo	marketed	Vasopressor agent; antidiuretic hormone	Vasopressin receptor V1a, V1b, and V2
Intracervical injection of Vasopressin	Intracervical injection of Vasopressin	Prisma Health-Upstate	marketed	Vasopressor agent	V1 vasopressin receptor
low-dose epinephrine and tranexamic acid	low-dose epinephrine and tranexamic acid	King Abdullah International Medical Research Center	marketed	Combination hemostatic and vasopressor agent	Alpha-1 and beta-1 adrenergic receptors (epinephrine); plasminogen and plasmin (tranexamic acid)
Angiotensin II Infusion	Angiotensin II Infusion	Massachusetts General Hospital	marketed	Vasopressor agent	Angiotensin II receptor (AT1 and AT2)
Vasopressin, Arginine	Vasopressin, Arginine	Lars Wiuff Andersen	marketed	Vasopressor agent; antidiuretic hormone	Vasopressin receptors (V1a, V1b, V2)
Early Vasopressin	Early Vasopressin	Hospital do Coracao	phase 3	Vasopressor agent	V1 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vasopressor agent class)

1. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
2. Hospital do Coracao · 1 drug in this class
3. Massachusetts General Hospital · 1 drug in this class
4. Prisma Health-Upstate · 1 drug in this class
5. The Cleveland Clinic · 1 drug in this class